[PHARMA] YoY TTM Result on 31-Mar-2016 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-May-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Mar-2016 [#1]
Profit Trend
QoQ- -15.96%
YoY- -28.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 2,553,141 2,323,589 2,248,121 2,276,603 2,126,165 1,914,972 1,865,940 5.36%
PBT 71,756 73,994 73,256 100,648 126,033 94,232 97,283 -4.94%
Tax -26,467 -20,676 -26,609 -29,520 -26,528 -35,978 -37,985 -5.84%
NP 45,289 53,318 46,647 71,128 99,505 58,254 59,298 -4.39%
-
NP to SH 44,499 52,386 46,143 70,629 99,421 56,646 57,797 -4.26%
-
Tax Rate 36.88% 27.94% 36.32% 29.33% 21.05% 38.18% 39.05% -
Total Cost 2,507,852 2,270,271 2,201,474 2,205,475 2,026,660 1,856,718 1,806,642 5.61%
-
Net Worth 528,825 524,838 544,360 515,906 528,173 515,022 484,829 1.45%
Dividend
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Div 44,226 51,913 41,456 69,935 80,234 42,973 41,189 1.19%
Div Payout % 99.39% 99.10% 89.84% 99.02% 80.70% 75.86% 71.27% -
Equity
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Net Worth 528,825 524,838 544,360 515,906 528,173 515,022 484,829 1.45%
NOSH 260,505 259,821 259,219 258,859 258,908 258,805 117,676 14.15%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin 1.77% 2.29% 2.07% 3.12% 4.68% 3.04% 3.18% -
ROE 8.41% 9.98% 8.48% 13.69% 18.82% 11.00% 11.92% -
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
RPS 980.07 894.30 867.27 879.48 821.20 739.93 1,585.65 -7.70%
EPS 17.08 20.16 17.80 27.28 38.40 21.89 49.11 -16.13%
DPS 17.00 20.00 16.00 27.00 31.00 16.61 35.00 -11.33%
NAPS 2.03 2.02 2.10 1.993 2.04 1.99 4.12 -11.12%
Adjusted Per Share Value based on latest NOSH - 258,859
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
RPS 177.15 161.22 155.98 157.96 147.52 132.87 129.47 5.36%
EPS 3.09 3.63 3.20 4.90 6.90 3.93 4.01 -4.24%
DPS 3.07 3.60 2.88 4.85 5.57 2.98 2.86 1.18%
NAPS 0.3669 0.3642 0.3777 0.358 0.3665 0.3573 0.3364 1.45%
Price Multiplier on Financial Quarter End Date
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Date 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 -
Price 2.27 4.28 4.89 5.76 6.00 4.46 8.26 -
P/RPS 0.23 0.48 0.56 0.65 0.73 0.60 0.52 -12.70%
P/EPS 13.29 21.23 27.47 21.11 15.62 20.38 16.82 -3.84%
EY 7.53 4.71 3.64 4.74 6.40 4.91 5.95 4.00%
DY 7.49 4.67 3.27 4.69 5.17 3.72 4.24 9.94%
P/NAPS 1.12 2.12 2.33 2.89 2.94 2.24 2.00 -9.20%
Price Multiplier on Announcement Date
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Date 16/05/19 16/05/18 16/05/17 13/05/16 18/05/15 14/05/14 15/05/13 -
Price 2.36 4.07 4.72 5.60 6.91 4.70 9.26 -
P/RPS 0.24 0.46 0.54 0.64 0.84 0.64 0.58 -13.67%
P/EPS 13.82 20.19 26.52 20.52 17.99 21.47 18.85 -5.03%
EY 7.24 4.95 3.77 4.87 5.56 4.66 5.30 5.33%
DY 7.20 4.91 3.39 4.82 4.49 3.53 3.78 11.33%
P/NAPS 1.16 2.01 2.25 2.81 3.39 2.36 2.25 -10.44%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment